Mitochondria as a pharmacological target: magnum overview

IUBMB Life. 2013 Mar;65(3):273-81. doi: 10.1002/iub.1147.

Abstract

Mitochondria, responsible for energy metabolism within the cell, act as signaling organelles. Mitochondrial dysfunction may lead to cell death and oxidative stress and may disturb calcium metabolism. Additionally, mitochondria play a pivotal role in cardioprotective phenomena and a variety of neurodegenerative disorders ranging from Parkinson's to Alzheimer's disease. Mitochondrial DNA mutations may lead to impaired respiration. Hence, targeting the mitochondria with drugs offers great potential for new therapeutic approaches. The purpose of this overview is to present the recent state of knowledge concerning the interactions of various substances with mitochondria.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / metabolism
  • Alzheimer Disease / pathology
  • Antioxidants / pharmacology
  • Cell Death / drug effects
  • DNA, Mitochondrial / agonists
  • DNA, Mitochondrial / antagonists & inhibitors
  • DNA, Mitochondrial / metabolism*
  • Electron Transport / drug effects*
  • Electron Transport / physiology
  • Enzyme Inhibitors / pharmacology
  • Humans
  • Ionophores / pharmacology
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Mitochondria / pathology
  • Mutation
  • Neuroprotective Agents / pharmacology
  • Oxidative Stress / drug effects
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Potassium Channel Blockers / pharmacology
  • Uncoupling Agents / pharmacology

Substances

  • Antioxidants
  • DNA, Mitochondrial
  • Enzyme Inhibitors
  • Ionophores
  • Neuroprotective Agents
  • Potassium Channel Blockers
  • Uncoupling Agents